![1]()
News
Buprenorphine endangers lives and health of children
June 25, 2018
Although important for treatment of opioid exposure, buprenorphine exposure can result in serious adverse effects in children who ingest it.
![1]()
News
A call for ‘changing the social norms’ on naloxone
June 19, 2018
SAN DIEGO – Among individuals with a history of injection drug use, more than one-third reported never or sometimes carrying naloxone, while just one in four reported carrying it with them at all times.
![1]()
News
Do free meals to physicians affect opioid prescribing?
June 19, 2018
SAN DIEGO – Physicians who received 1 free meal made about 150 opioid claims; those who received more than 10 made more than 700 claims.
![1]()
News
High-dose opioid prescribing linked to heroin use risk among U.S. veterans
June 13, 2018
SAN DIEGO – High-dose opioid prescribing is associated with an increased risk of heroin use among U.S. veterans, an observational study showed.
![1]()
News
NIH launches HEAL Initiative to combat opioid crisis
June 12, 2018
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of neonatal opioid withdrawal syndrome (NOWS), understand current management approaches, and develop common approaches for larger-scale studies to decide the best practices for clinical care of infants with NOWS.
![1]()
News
CDC warns of hepatitis A outbreaks in injection drug users
June 11, 2018
Gap in vaccine availability now has been solved.
Video
VIDEO: Pills alone not the answer for pain management
May 19, 2018
SANDESTIN, FLA. – A variety of approaches to pain management is absolutely crucial in the area of opioid abuse.
![1]()
News
Beware nonopiate meds with high street value
April 25, 2018
NEW ORLEANS – Use these safeguards when prescribing gabapentin and other high-abuse-potential drugs.
![1]()
News
Synthetic opioids drive increase in overdose deaths
March 29, 2018
Illegally manufactured fentanyl is now being combined with other drugs.
![1]()
News
FDA advisors recommend lofexidine for opioid withdrawal
March 27, 2018
SILVER SPRING, MD. – A nonopioid agent for symptomatic treatment of opioid withdrawal could be another option to address the opioid epidemic.
